President Donald Trump and Health and Human Services Secretary Robert F. Kennedy Jr . unveiled a series of initiatives on Sept. 22 aimed at addressing the rising rates of autism spectrum disorder (ASD) in the United States. The announcement included claims about prenatal use of Tylenol (acetaminophen), warnings for pregnant individuals and regulatory changes to support autism treatments.

The U.S. Food and Drug Administration (FDA) has approved leucovorin , a folic acid derivative, for treating symptoms associated with cerebral folate deficiency (CFD), which often overlap with autism-like neuropsychiatric symptoms. This move formalizes a treatment pathway for children showing speech, social or adaptive deficits where CFD is identified.

President Trump asserted in a White House brief

See Full Page